Skoči na glavni sadržaj

Izvorni znanstveni članak

Arterial hypertension following COVID-19: A retrospective study of patients in a Central European tertiary care center

Điđi Delalić ; Medical School, University of Zagreb, Zagreb, Croatia
Juraj Jug orcid id ; Health Center Zagreb West
Ingrid Prkačin orcid id ; Medical School, University of Zagreb, Zagreb, Croatia; Merkur University Hospital, Zagreb, Croatia

Puni tekst: engleski pdf 1.373 Kb

str. 23-26

preuzimanja: 373



The aim of this study was to determine the frequency of newly verified or worsened
existing hypertension in patients who had coronavirus 2019 (COVID-19).
To be categorized as a COVID-19 patient, a positive reverse-transcription polymerase chain reaction
test at a single point in time was required. The patients’ age, history, laboratory values and antihypertensive
therapy of patients were recorded.
In one year, 32 of 199 patients studied had either newly verified (15) or worsened existing (17)
arterial hypertension. Among those patients, the median time from a verified infection to the onset of
symptoms was 3 months. When the patients were divided into groups, 4 were in the acute, 11 in the
sub-acute, 8 in the chronic and 9 in the “long COVID” group. Compared to the rest of the study
population, patients presenting with arterial hypertension had significantly higher systolic (median
141 mmHg vs 130 mmHg, p<0.001) and diastolic (median 93 mmHg vs 80 mmHg, p<0.001) blood
pressure and were significantly younger (median 51 vs 59 years, p 0.032).
Arterial hypertension following COVID-19, either newly verified or worsened existing, is a relatively
common occurrence (16% of our patient pool), indicating that more effort should be directed at
evaluating the blood pressure values of patients following COVID-19.

Ključne riječi

arterial hypertension; COVID-19 infection; post-Covid

Hrčak ID:



Datum izdavanja:


Podaci na drugim jezicima: hrvatski

Posjeta: 1.023 *